Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?
- 1 April 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (4) , 628-636
- https://doi.org/10.1161/01.atv.0000116216.56511.39
Abstract
Genetic susceptibility tests are already advertised on the Internet to identify individuals at above average risk for cardiovascular disease (CVD), such as deep vein thrombosis, hyperlipidemia, or atherosclerosis, whereas other tests claim to predict response to a particular drug treatment. Some kits are available to the public directly, bypassing a doctor. Their value, however, must be considered carefully, because although a genotype may be strongly and consistently associated with an intermediate trait, and because the intermediate trait is a strong predictor of CVD risk, there may be little or no association of genotype with risk over and above that of the measured trait. This is because multigenic effects and environmental modification (context dependency) of genotype effects determine CVD risk. An individual’s personal characteristics and plasma risk-trait levels (which reflect both genotype and exposure) at present are the best predictors of clinical outcome. Only when genetic tests surpass this, p...Keywords
This publication has 65 references indexed in Scilit:
- Improving the Prediction of Complex Diseases by Testing for Multiple Disease-Susceptibility GenesAmerican Journal of Human Genetics, 2003
- Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate GenesNew England Journal of Medicine, 2002
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaBMJ, 2002
- Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic diseaseBMJ, 2001
- A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United KingdomEuropean Journal of Human Genetics, 2001
- Review of first 5 years of screening for familial hypercholesterolaemia in the NetherlandsThe Lancet, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Sequence Diversity in 36 Candidate Genes for Cardiovascular DisordersAmerican Journal of Human Genetics, 1999
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986